Healthcare -
Biotechnology - NASDAQ - US
$ 4.01
-5.87 %
$ 48.5 M
Market Cap
-1.9
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
25.99%
Net Income
Estimate
61.20%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
NRx Pharmaceuticals, Inc.
NRXP has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart NRXP
EBIT FORECAST
EBIT Forecast Chart NRXP
NET INCOME FORECAST
Net Income Chart NRXP